IN2013MU03422A - - Google Patents

Info

Publication number
IN2013MU03422A
IN2013MU03422A IN3422MU2013A IN2013MU03422A IN 2013MU03422 A IN2013MU03422 A IN 2013MU03422A IN 3422MU2013 A IN3422MU2013 A IN 3422MU2013A IN 2013MU03422 A IN2013MU03422 A IN 2013MU03422A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
sulbactam
stereoisomer
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3422MU2013 priority Critical patent/IN2013MU03422A/en
Priority to EP14806075.9A priority patent/EP3062793A1/de
Priority to RU2016115375A priority patent/RU2016115375A/ru
Priority to MX2016005539A priority patent/MX2016005539A/es
Priority to CN201480059506.8A priority patent/CN106163519A/zh
Priority to AU2014343327A priority patent/AU2014343327A1/en
Priority to PCT/IB2014/065523 priority patent/WO2015063653A1/en
Priority to CA2928368A priority patent/CA2928368A1/en
Priority to US15/030,607 priority patent/US20160287571A1/en
Priority to JP2016526935A priority patent/JP2016535038A/ja
Publication of IN2013MU03422A publication Critical patent/IN2013MU03422A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3422MU2013 2013-10-30 2014-10-22 IN2013MU03422A (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN3422MU2013 IN2013MU03422A (de) 2013-10-30 2014-10-22
EP14806075.9A EP3062793A1 (de) 2013-10-30 2014-10-22 Pharmazeutische zusammensetzungen mit antibakteriellen wirkstoffen
RU2016115375A RU2016115375A (ru) 2013-10-30 2014-10-22 Фармацевтические композиции, содержащие антибактериальные агенты
MX2016005539A MX2016005539A (es) 2013-10-30 2014-10-22 Composiciones farmaceuticas que comprenden agentes antibacterianos.
CN201480059506.8A CN106163519A (zh) 2013-10-30 2014-10-22 包含抗菌剂的药物组合物
AU2014343327A AU2014343327A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
PCT/IB2014/065523 WO2015063653A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
CA2928368A CA2928368A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
US15/030,607 US20160287571A1 (en) 2013-10-30 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
JP2016526935A JP2016535038A (ja) 2013-10-30 2014-10-22 抗菌剤を含む医薬品組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3422MU2013 IN2013MU03422A (de) 2013-10-30 2014-10-22

Publications (1)

Publication Number Publication Date
IN2013MU03422A true IN2013MU03422A (de) 2015-07-17

Family

ID=52003013

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3422MU2013 IN2013MU03422A (de) 2013-10-30 2014-10-22

Country Status (10)

Country Link
US (1) US20160287571A1 (de)
EP (1) EP3062793A1 (de)
JP (1) JP2016535038A (de)
CN (1) CN106163519A (de)
AU (1) AU2014343327A1 (de)
CA (1) CA2928368A1 (de)
IN (1) IN2013MU03422A (de)
MX (1) MX2016005539A (de)
RU (1) RU2016115375A (de)
WO (1) WO2015063653A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016151543A1 (en) * 2015-03-25 2016-09-29 Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
EP3719020B1 (de) 2017-12-01 2022-09-21 Qilu Pharmaceutical Co., Ltd. Kristalline form von beta-lactamase-inhibitor und herstellungsverfahren dafür

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2748165T3 (pl) * 2011-08-27 2017-05-31 Wockhardt Limited Pochodne 1,6-diazabicyklo[3,2,1]oktan-7-onu i ich zastosowanie w leczeniu zakażeń bakteryjnych

Also Published As

Publication number Publication date
RU2016115375A3 (de) 2018-07-18
CA2928368A1 (en) 2015-05-07
CN106163519A (zh) 2016-11-23
EP3062793A1 (de) 2016-09-07
AU2014343327A1 (en) 2016-05-12
MX2016005539A (es) 2016-10-03
WO2015063653A1 (en) 2015-05-07
RU2016115375A (ru) 2017-12-01
US20160287571A1 (en) 2016-10-06
JP2016535038A (ja) 2016-11-10

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
MX2018002986A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos.
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
IN2014MN02598A (de)
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
MY162886A (en) Novel tetrahydropyridopyrimidine compound or salt thereof
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2016001138A (es) Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo.
EP3003360A4 (de) Hochwirksame pharmazeutische pankreatinzusammensetzungen
AU2015292632B2 (en) Aldosterone synthase inhibitors
IN2013MU01985A (de)
IN2013MU03422A (de)
IN2013MU03704A (de)
IN2013MU03308A (de)
IN2013MU03309A (de)
IN2014MU00859A (de)
IN2013MU03421A (de)
IN2013MU03565A (de)
IN2013CH04314A (de)
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.